Annovis Bio Inc (NY: ANVS )
16.58
+2.98
(+21.91%)
Streaming Delayed Price
Updated: 2:07 PM EDT, Apr 26, 2024
Add to My Watchlist
All News about Annovis Bio IncVia Benzinga
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
January 25, 2022
Via Newsfile
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|